Allianz Asset Management GmbH - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,969,000
-62.9%
207,025
-25.9%
0.00%
-75.0%
Q4 2021$5,311,000
-41.8%
279,206
+1.8%
0.00%
-42.9%
Q3 2021$9,131,000
+1.9%
274,369
+18.8%
0.01%
-12.5%
Q2 2021$8,960,000
+36.2%
230,975
+69.3%
0.01%
+33.3%
Q1 2021$6,577,000
+2.4%
136,461
+10.6%
0.01%0.0%
Q4 2020$6,420,000
+59.0%
123,421
-18.2%
0.01%
+20.0%
Q3 2020$4,037,000
+55.3%
150,874
+13.1%
0.01%
+66.7%
Q2 2020$2,600,000
+145.1%
133,457
+23.8%
0.00%
+200.0%
Q1 2020$1,061,000
-34.9%
107,836
-26.6%
0.00%0.0%
Q4 2019$1,630,000
+71.6%
146,891
-13.4%
0.00%0.0%
Q3 2018$950,000
-53.5%
169,628
+9.2%
0.00%
-50.0%
Q2 2018$2,042,000
-7.9%
155,312
-0.6%
0.00%0.0%
Q1 2018$2,218,000
+96.1%
156,211
+13.2%
0.00%
+100.0%
Q4 2017$1,131,000
-26.2%
137,980
+6.6%
0.00%0.0%
Q3 2017$1,533,000
+22.2%
129,378
+3.6%
0.00%0.0%
Q2 2017$1,255,000124,8480.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders